Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92594937 | 9259493 | 7 | F | 2012 | 20160630 | 20130428 | 20160708 | EXP | US-009507513-1304USA014374 | MERCK | 0.00 | F | Y | 0.00000 | 20160708 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92594937 | 9259493 | 1 | PS | REMERON | MIRTAZAPINE | 1 | Oral | UNK | U | 20415 | TABLET | ||||||||
| 92594937 | 9259493 | 2 | SS | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 15 MG, UNK | 0 | 15 | MG | ||||||||
| 92594937 | 9259493 | 3 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 92594937 | 9259493 | 4 | SS | RISPERDAL | RISPERIDONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92594937 | 9259493 | 1 | Schizophrenia |
| 92594937 | 9259493 | 2 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92594937 | 9259493 | OT |
| 92594937 | 9259493 | HO |
| 92594937 | 9259493 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92594937 | 9259493 | Abdominal pain | |
| 92594937 | 9259493 | Balance disorder | |
| 92594937 | 9259493 | Benign neoplasm of eye | |
| 92594937 | 9259493 | Blindness | |
| 92594937 | 9259493 | Body mass index increased | |
| 92594937 | 9259493 | Breast enlargement | |
| 92594937 | 9259493 | Gastrooesophageal reflux disease | |
| 92594937 | 9259493 | Gliosis | |
| 92594937 | 9259493 | Headache | |
| 92594937 | 9259493 | High density lipoprotein decreased | |
| 92594937 | 9259493 | Hydrocephalus | |
| 92594937 | 9259493 | Intracranial pressure increased | |
| 92594937 | 9259493 | Major depression | |
| 92594937 | 9259493 | Nausea | |
| 92594937 | 9259493 | Obesity | |
| 92594937 | 9259493 | Ocular hypertension | |
| 92594937 | 9259493 | Optic nerve disorder | |
| 92594937 | 9259493 | Papilloedema | |
| 92594937 | 9259493 | Shunt malfunction | |
| 92594937 | 9259493 | Sleep apnoea syndrome | |
| 92594937 | 9259493 | Tension headache | |
| 92594937 | 9259493 | Ventricular drainage | |
| 92594937 | 9259493 | Vision blurred | |
| 92594937 | 9259493 | Vitamin B12 decreased | |
| 92594937 | 9259493 | Vitamin D deficiency | |
| 92594937 | 9259493 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92594937 | 9259493 | 1 | 201204 | 0 | ||
| 92594937 | 9259493 | 2 | 20120618 | 201212 | 0 |